tailieunhanh - Prostate cancer: diagnosis and treatment

Neoadjuvant and concurrent luteinising hormone-releasing hormone agonist (LHRHa) therapy is recommended for 3 to 6 months in men receiving radical radiotherapy for locally advanced prostate cancer. Adjuvant hormonal therapy in addition to radical prostatectomy is not recommended, even in men with margin-positive disease, other than in the context of a clinical trial 10 . Adjuvant hormonal therapy is recommended for a minimum of 2 years in men receiving radi- cal radiotherapy for locally advanced prostate cancer who have a Gleason score of ≥ 8. Bisphosphonates should not be used for the prevention of bone metastases in men. | Prostate cancer diagnosis and treatment Full Guideline February 2008 Developed for NICE by the National Collaborating Centre for Cancer Prostate cancer diagnosis and treatment February .

TỪ KHÓA LIÊN QUAN
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.